176 related articles for article (PubMed ID: 37929591)
1. Economic Modeling Analysis of an Intensive GDMT Optimization Program in Hospitalized Heart Failure Patients.
Dixit NM; Parikh NU; Ziaeian B; Fonarow GC
Circ Heart Fail; 2023 Dec; 16(12):e011218. PubMed ID: 37929591
[TBL] [Abstract][Full Text] [Related]
2. Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Desai AS; Maclean T; Blood AJ; Bosque-Hamilton J; Dunning J; Fischer C; Fera L; Smith KV; Wagholikar K; Zelle D; Gaziano T; Plutzky J; Scirica B; MacRae CA
JAMA Cardiol; 2020 Dec; 5(12):1430-1434. PubMed ID: 32936209
[TBL] [Abstract][Full Text] [Related]
3. Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study.
Bhatt AS; Varshney AS; Nekoui M; Moscone A; Cunningham JW; Jering KS; Patel PN; Sinnenberg LE; Bernier TD; Buckley LF; Cook BM; Dempsey J; Kelly J; Knowles DM; Lupi K; Malloy R; Matta LS; Rhoten MN; Sharma K; Snyder CA; Ting C; McElrath EE; Amato MG; Alobaidly M; Ulbricht CE; Choudhry NK; Adler DS; Vaduganathan M
Eur J Heart Fail; 2021 Jul; 23(7):1191-1201. PubMed ID: 33768599
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
Baron SJ; Wang K; Arnold SV; Magnuson EA; Whisenant B; Brieke A; Rinaldi M; Asgar AW; Lindenfeld J; Abraham WT; Mack MJ; Stone GW; Cohen DJ;
Circulation; 2019 Dec; 140(23):1881-1891. PubMed ID: 31564137
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
[TBL] [Abstract][Full Text] [Related]
6. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
[TBL] [Abstract][Full Text] [Related]
7. The Optimization of Guideline-Directed Medical Therapy during Hospitalization among Patients with Heart Failure with Reduced Ejection Fraction in Daily Clinical Practice.
Bánfi-Bacsárdi F; Muk B; Pilecky D; Duray GZ; Kiss RG; Nyolczas N
Cardiology; 2023; 148(1):27-37. PubMed ID: 36470212
[TBL] [Abstract][Full Text] [Related]
8. Representativeness of the GALACTIC-HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction.
Mefford MT; Koyama SY; De Jesus J; Wei R; Fischer H; Harrison TN; Woo P; Reynolds K
J Am Heart Assoc; 2022 Apr; 11(7):e023766. PubMed ID: 35322672
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers about treatment of heart failure (PROMPT-HF).
Ghazi L; Desai NR; Simonov M; Yamamoto Y; O'Connor KD; Riello RJ; Huang J; Olufade T; McDermott J; Inzucchi SE; Velazquez EJ; Wilson FP; Ahmad T
Am Heart J; 2022 Feb; 244():107-115. PubMed ID: 34808104
[TBL] [Abstract][Full Text] [Related]
10. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial.
Cotter G; Deniau B; Davison B; Edwards C; Adamo M; Arrigo M; Barros M; Biegus J; Celutkiene J; Cerlinskaite-Bajore K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Metra M; Novosadova M; Pang PS; Pagnesi M; Ponikowski P; Saidu H; Sliwa K; Takagi K; Ter Maaten JM; Tomasoni D; Voors A; Mebazaa A
JAMA Cardiol; 2024 Feb; 9(2):114-124. PubMed ID: 38150260
[TBL] [Abstract][Full Text] [Related]
11. Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry.
Schrage B; Lund LH; Benson L; Braunschweig F; Ferreira JP; Dahlström U; Metra M; Rosano GMC; Savarese G
Eur J Heart Fail; 2023 Jul; 25(7):1132-1144. PubMed ID: 37317585
[TBL] [Abstract][Full Text] [Related]
12. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial.
Tomasoni D; Davison B; Adamo M; Pagnesi M; Mebazaa A; Edwards C; Arrigo M; Barros M; Biegus J; Čelutkienė J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Novosadova M; Pang PS; Ponikowski P; Saidu H; Sliwa K; Takagi K; Maaten JMT; Voors A; Cotter G; Metra M
J Card Fail; 2024 Apr; 30(4):525-537. PubMed ID: 37820896
[TBL] [Abstract][Full Text] [Related]
13. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
Ghazi L; Yamamoto Y; Riello RJ; Coronel-Moreno C; Martin M; O'Connor KD; Simonov M; Huang J; Olufade T; McDermott J; Dhar R; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
J Am Coll Cardiol; 2022 Jun; 79(22):2203-2213. PubMed ID: 35385798
[TBL] [Abstract][Full Text] [Related]
14. In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial.
Rao VN; Shah A; McDermott J; Barnes SG; Murray EM; Kelsey MD; Greene SJ; Fudim M; DeVore AD; Patel CB; Blazing MA; O'Brien C; Mentz RJ
Circ Heart Fail; 2023 Feb; 16(2):e010158. PubMed ID: 36314130
[TBL] [Abstract][Full Text] [Related]
15. DASH-HF Study: A Pragmatic Quality Improvement Randomized Implementation Trial for Patients With Heart Failure With Reduced Ejection Fraction.
Verma A; Fonarow GC; Hsu JJ; Jackevicius CA; Vaghaiwalla Mody F; Nguyen A; Amidi O; Goldberg S; Vetrivel R; Upparapalli D; Theodoropoulos K; Gregorio S; Chang DS; Bostrom K; Althouse AD; Ziaeian B
Circ Heart Fail; 2023 Sep; 16(9):e010278. PubMed ID: 37494051
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
[TBL] [Abstract][Full Text] [Related]
17. A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients.
Matsukawa R; Okahara A; Tokutome M; Itonaga J; Koga E; Hara A; Kisanuki H; Sada M; Okabe K; Kawai S; Ogawa K; Matsuura H; Mukai Y
ESC Heart Fail; 2023 Dec; 10(6):3352-3363. PubMed ID: 37671603
[TBL] [Abstract][Full Text] [Related]
18. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial.
Cox ZL; Zalawadiya SK; Simonato M; Redfors B; Zhou Z; Kotinkaduwa L; Zile MR; Udelson JE; Lim DS; Grayburn PA; Mack MJ; Abraham WT; Stone GW; Lindenfeld J
JACC Heart Fail; 2023 Jul; 11(7):791-805. PubMed ID: 37115135
[TBL] [Abstract][Full Text] [Related]
19. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
[TBL] [Abstract][Full Text] [Related]
20. Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
Izumi K; Kohno T; Goda A; Takeuchi S; Shiraishi Y; Saji M; Nagatomo Y; Tanaka TD; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
Int J Cardiol; 2023 Jan; 370():255-262. PubMed ID: 36270494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
